gip and glp 1 drugs Indications for GLP-1/GIP RA Summary Sheet Beyond! GLP-1 receptor agonists | How

White-space opportunities extend to oral formulations and multi-indication positioning for cardio-renal protection

Endocrinology Advisor Conclusion The 2025 GLP-1 guidelines reflect a paradigm shift in the management of type 2 diabetes, emphasizing the multifaceted benefits of these agents

Diabetic patients should have a baseline eye examination around the time of GLP-1/GIP agonist treatment initiation to determine the level of retinopathy and presence of DME

PMID 41459016

doi: 10.1124/mol.116.107102 106 FanHGongNLiTFMaANWuXYWangMWet al

However, the publicized research shows the treatments growth potential in the obesity treatment market